Therapeutic target for multiple myeloma CD38
2024-04-24
CD38 is a transmembrane glycoprotein with exoenzyme activity that also functions as a receptor and adhesion molecule. CD38 is expressed at low levels in normal lymphocytes, myeloid...
Detection of small molecule ethylpyrimol residues in agricultural products and environment
2024-04-24
Background:Ethylpyrimidine, a typical pyrimidine fungicide, has been widely used for over 50 years to control powdery mildew on various fruits and vegetables. Excessive use of ethy...
Functional IgG-like stability and pharmacological studies of tetravalent bispecific antibodies
2024-04-23
BackgroundBispecific antibodies (bsAbs) are a promising drug modality that can simultaneously bind to two distinct epitopes on the same or different antigens. So far, 14 bsAb drugs...
The scavenger receptor CD36
2024-04-18
CD36 is a scavenger receptor expressed in multiple cell types that mediates lipid uptake, immune recognition, inflammation, molecular adhesion and cell apoptosis. It plays an impor...
CD33 is a potential therapeutic target
2024-04-16
CD33 is a cell surface protein belonging to the sialic acid-binding immunoglobulin-like lectins (Siglecs) family. It is a transmembrane protein that plays an important role in medi...
The complement receptor CD35
2024-04-15
CD35, also known as complement receptor 1 (CR1), plays a crucial role in the complement system. The complement system is part of the immune system and, through a series of cascades...
Potential tumor therapeutic target CD25
2024-03-21
The interleukin-2 receptor (IL-2R) is composed of three subunits: α (IL-2Rα , CD25), β (IL-2Rβ, CD122), and γ common (IL-2Rγ, CD132). CD25 is the only subunit of the IL-2 receptor ...